Download 
|
< Back |
| 03:46 PM | |
| Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. Please find enclosed intimation in this regard | |
| View all announcements for Bliss GVS Pharma Ltd | Source: BSE India |
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback